Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06203691 · ClinicalTrials.gov registry record · NA

Nirvana Super Pro Supplementation in Orthopedic Surgery Patients

A NA study of Arthropathy of Knee and Arthropathy of Hip, sponsored by Nirvana Water Sciences.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06203691: Recruiting NA study of Arthropathy of Knee and Arthropathy of Hip, sponsored by Nirvana Water Sciences.

NCT06203691 is a NA study of Arthropathy of Knee and Arthropathy of Hip that is actively recruiting participants, run by Nirvana Water Sciences. The registered enrollment target is 100 participants, above the 77-participant average among 6 other Arthropathy of Knee trials with a reported enrollment target (30% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06203691, a NA study of Arthropathy of Knee and Arthropathy of Hip, is actively recruiting participants, sponsored by Nirvana Water Sciences.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate orthopedic patients undergoing either a total hip replacement (THR) or total knee arthroplasty (TKR) using two dietary supplements, PREPARE and RECOVER, and their recovery times post-surgery.

Interventions

  • DIETARY_SUPPLEMENT Supplementation with Nirvana Super Pro Liquid Supplements
  • DIETARY_SUPPLEMENT Non-Supplementation Group

Study Locations (1)

Pennsylvania

  • University Orthopedics Center - Altoona

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-02-21
Est. Completion 2024-08-30
Phase NA
Nirvana Water Sciences

1 total trials

What NCT06203691 shows while recruiting

NCT06203691 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 77-participant average among 6 other Arthropathy of Knee trials with a reported enrollment target (30% higher).

The record links to 2 conditions, with Arthropathy of Knee appearing as the primary indexed condition, and to 2 interventions - of which Supplementation with Nirvana Super Pro Liquid Supplements is the first listed.

NCT06203691 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06203691 about?

NCT06203691 is a clinical study titled "Nirvana Super Pro Supplementation in Orthopedic Surgery Patients". The purpose of this study is to investigate orthopedic patients undergoing either a total hip replacement (THR) or total knee arthroplasty (TKR) using two dietary supplements, PREPARE and RECOVER, and their recovery times post-surgery.

What is the current status of trial NCT06203691?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-02-21. Estimated completion is 2024-08-30.

What conditions does trial NCT06203691 study?

This clinical trial studies the following conditions: Arthropathy of Knee, Arthropathy of Hip.

What interventions are being tested in trial NCT06203691?

The interventions under investigation include: Supplementation with Nirvana Super Pro Liquid Supplements (DIETARY_SUPPLEMENT), Non-Supplementation Group (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06203691?

This trial is sponsored by Nirvana Water Sciences, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06203691 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Arthropathy of Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06203691, the US trial registry maintained by the National Library of Medicine. NCT06203691 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.